It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
Daniel W.Excellent question! The DCB technology with Sirolimus is emerging and many companies are active in this field, as BBRAUN, Mynvasis, Concept Medical, Orchestra Biomed. The data are scarce and conclusions preliminary. Seems to have the potential to be equal. Preliminarny clinical data are positive mainly for ISR, less for small vessels. SBut I think can be the choice of the future. As it is difficult to create a DCB with the hydrophilic Sirolimus, there can be differences between the sirolimus DCBs, as senn with the Pclitaxel DCBs. Hope that helps.
Join files
Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
Your browser doesn't have Flash, Silverlight or HTML5 support.
anwar D. Results with Sirolimus coated Drug balloons ??
Daniel W. Excellent question! The DCB technology with Sirolimus is emerging and many companies are active in this field, as BBRAUN, Mynvasis, Concept Medical, Orchestra Biomed. The data are scarce and conclusions preliminary. Seems to have the potential to be equal. Preliminarny clinical data are positive mainly for ISR, less for small vessels. SBut I think can be the choice of the future. As it is difficult to create a DCB with the hydrophilic Sirolimus, there can be differences between the sirolimus DCBs, as senn with the Pclitaxel DCBs. Hope that helps.